Literature DB >> 30467699

Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.

Enrique Bellolio1,2, Ismael Riquelme3, Angela L Riffo-Campos4,5, Carlos Rueda6, Catterina Ferreccio7,8, Miguel Villaseca4,9, Priscilla Brebi4,10, Sergio Muñoz11, Juan Carlos Araya4,9.   

Abstract

Gastric cancer (GC) is the first cancer-related cause of death in Chile; however, no plan for GC early detection has been implemented in this country. The OLGA system characterizes gastritis from stages 0 to IV according to the risk of developing GC based on H. pylori infection, atrophy, metaplasia and GC. In this study, the performance of the OLGA system was evaluated in 485 Chilean patients receiving routine endoscopy to improve the detection of early GC or preneoplastic lesions. The results showed that OLGA scores, atrophy, metaplasia and GC increased significantly with age (p < 0.001). Conversely, H. pylori infection was higher in younger groups (p < 0.05). All gastric lesions were more frequent in men than women. The majority of patients with atrophy also had metaplasia (99%, p < 0.0001). Patients with H. pylori infection had more gastric atrophy and metaplasia than those without infection (p < 0.05). Of the 485 patients, 21 (4.3%) had GC, being 2.3 times more frequent among men than women and about 2/3 (14) were in OLGA stage ≥2. In addition, 19 (90%) GC patients had atrophy and 18 (85%) had metaplasia (p < 0.001). In conclusion, the OLGA system facilitated the evaluation of GC precursor lesions particularly in patients with an OLGA score > 2 between 45 and 56 years old, because this group showed atrophy and intestinal metaplasia more frequently. Therefore, biennial endoscopic surveillance of patients with an OLGA >2 can be an important health policy in Chile for diagnosing GC in its early stages and reducing mortality over the next two decades.

Entities:  

Keywords:  Chilean population; Gastric atrophy; Gastric cancer; Helicobacter pylori infection; Metaplasia; The OLGA system

Mesh:

Year:  2018        PMID: 30467699     DOI: 10.1007/s12253-018-0532-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  4 in total

1.  Prevalence of Gastric Preneoplastic Lesions in First-Degree Relatives of Patients with Gastric Cancer: a Cross-Sectional Study.

Authors:  Sergio Sotelo; Carlos Manterola; Tamara Otzen; Erik Morales; Iván Castillo
Journal:  J Gastrointest Cancer       Date:  2022-04-30

2.  Can Simple Tests Prior to Endoscopy Predict the OLGA Stage of Gastritis?

Authors:  Ertan Bulbuloglu; Hasan Dagmura; Emin Daldal; Alev Deresoy; Huseyin Bakir; Ugur Ozsoy; Ali Ihsan Saglam; Osman Demir
Journal:  Healthcare (Basel)       Date:  2020-07-24

3.  Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China.

Authors:  Xujuan Liu; Min Zhang; Riyu Luo; Keran Mo; Xingxiang He
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

4.  Isolation, Gastroprotective Effects and Untargeted Metabolomics Analysis of Lycium Minutifolium J. Remy (Solanaceae).

Authors:  Stephanie Rodriguez; Mariano Walter Pertino; Chantal Arcos; Luana Reichert; Javier Echeverria; Mario Simirgiotis; Jorge Borquez; Alberto Cornejo; Carlos Areche; Beatriz Sepulveda
Journal:  Foods       Date:  2020-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.